nicotine polacrilex lozenge mint

Generic: nicotine polacrilex lozenge 2 mg

Labeler: chain drug marketing association inc
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nicotine polacrilex lozenge mint
Generic Name nicotine polacrilex lozenge 2 mg
Labeler chain drug marketing association inc
Dosage Form LOZENGE
Routes
ORAL
Active Ingredients

nicotine 2 mg/1

Manufacturer
Chain Drug Marketing Association INC

Identifiers & Regulatory

Product NDC 63868-733
Product ID 63868-733_618550c1-391c-c6a7-c2b5-19d3bfc78419
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA212796
Listing Expiration 2026-12-31
Marketing Start 2021-04-01

Pharmacologic Class

Established (EPC)
cholinergic nicotinic agonist [epc]
Chemical Structure
nicotine [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63868733
Hyphenated Format 63868-733

Supplemental Identifiers

RxCUI
359817 359818
UNII
6M3C89ZY6R
NUI
N0000175706 M0014836

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nicotine polacrilex lozenge mint (source: ndc)
Generic Name nicotine polacrilex lozenge 2 mg (source: ndc)
Application Number ANDA212796 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (63868-733-24) / 24 LOZENGE in 1 BOTTLE
  • 3 BOTTLE in 1 CARTON (63868-733-72) / 24 LOZENGE in 1 BOTTLE
source: ndc

Packages (2)

Ingredients (1)

nicotine (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "618550c1-391c-c6a7-c2b5-19d3bfc78419", "openfda": {"nui": ["N0000175706", "M0014836"], "unii": ["6M3C89ZY6R"], "rxcui": ["359817", "359818"], "spl_set_id": ["e0234492-d92d-ee93-493f-1099d4544722"], "pharm_class_cs": ["Nicotine [CS]"], "pharm_class_epc": ["Cholinergic Nicotinic Agonist [EPC]"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63868-733-24)  / 24 LOZENGE in 1 BOTTLE", "package_ndc": "63868-733-24", "marketing_start_date": "20210401"}, {"sample": false, "description": "3 BOTTLE in 1 CARTON (63868-733-72)  / 24 LOZENGE in 1 BOTTLE", "package_ndc": "63868-733-72", "marketing_start_date": "20210401"}], "brand_name": "Nicotine Polacrilex Lozenge Mint", "product_id": "63868-733_618550c1-391c-c6a7-c2b5-19d3bfc78419", "dosage_form": "LOZENGE", "pharm_class": ["Cholinergic Nicotinic Agonist [EPC]", "Nicotine [CS]"], "product_ndc": "63868-733", "generic_name": "Nicotine Polacrilex Lozenge 2 mg", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Nicotine Polacrilex Lozenge Mint", "active_ingredients": [{"name": "NICOTINE", "strength": "2 mg/1"}], "application_number": "ANDA212796", "marketing_category": "ANDA", "marketing_start_date": "20210401", "listing_expiration_date": "20261231"}